Summary of Key Points Core Viewpoint - The article reflects on the significant decline in Moderna's stock price since 2021, when shares were priced around $500, indicating a notable shift in market perception and valuation of the company [1]. Company Performance - In 2021, Moderna shares were approximately $500 each, meaning an investment of 100 shares would have cost about $50,000 [1]. Investment Strategy - The author emphasizes a long-term investment strategy focused on strategic buying opportunities, particularly in dividend and value stocks, which has garnered a high rating on investment platforms [1].

Group 1 - The S&P 500 index achieved a "six-day winning streak," reflecting strong resilience in the U.S. stock market, with a closing price of 5963.6 points, just 3% away from its historical high [1] - The S&P 500 index has rebounded 17% since its low at the end of April [1] - The pharmaceutical and precious metals sectors performed notably well, with Novavax rising over 15%, UnitedHealth up over 8%, and Moderna increasing over 6% [1] Group 2 - In the Chinese concept stock sector, the Nasdaq Golden Dragon China Index fell by 0.17%, with Bilibili down nearly 5% and XPeng down over 3% [2] - Xiaomi Group's ADR, which is set to release its self-developed 3nm chip, saw a notable increase of 3.66% [2] - WTI crude oil futures closed at $62.69 per barrel, up 0.32%, while Brent crude oil futures rose to $65.54 per barrel, up 0.2% [2] Group 3 - Federal Reserve's Bostic indicated that Moody's downgrade will impact the entire economy and financial markets, suggesting a wait of 3 to 6 months to see how uncertainties resolve [3] - Market analysts have differing views on the Moody's downgrade, with Morgan Stanley's chief equity strategist viewing it as a buying opportunity, while UBS recommends gradual stock asset allocation, favoring sectors like communication services, information technology, healthcare, and utilities [3]

Market Overview - On Monday, US stock indices opened lower but closed with slight gains, with the Dow Jones up 0.32%, Nasdaq up 0.02%, and S&P 500 up 0.09% [1] - The pharmaceutical and precious metals sectors saw significant gains, with Novavax rising over 15%, UnitedHealth up over 8%, and Moderna up over 6% [1] - In contrast, the solar, automotive, and oil & gas sectors experienced declines, with First Solar down over 7% and Murphy Oil down over 2% [1] - Most popular Chinese stocks fell, with the Nasdaq Golden Dragon China Index down 0.17% [1] Credit Rating Downgrade - Moody's announced a downgrade of the US sovereign credit rating from Aaa to Aa1 due to increased government debt and interest payment ratios [1] - This downgrade marks the first trading day following the announcement, and the US has now lost its highest credit rating from all three major international credit rating agencies [1] - White House National Economic Council Director Kevin Hassett described the downgrade as "lagging" and reaffirmed the safety of US Treasury bonds [1] Federal Reserve's Stance - Several Federal Reserve officials indicated that the economic outlook remains uncertain, suggesting that the Fed may not be ready to lower interest rates before September [2] - Fed Vice Chair Jefferson emphasized the need to monitor the impact of policy changes from the Trump administration on inflation [2] - New York Fed President Williams stated that it may take several months to gain clarity on the economic outlook, indicating a cautious approach to policy adjustments [2][3] Economic Uncertainty - Williams noted that while inflation has decreased and the economy is nearing full employment, attention is still required on default rates and consumer spending trends [3] - Atlanta Fed President Bostic echoed similar sentiments, suggesting a wait-and-see approach for 3 to 6 months to better understand economic conditions [3] - The Fed is currently balancing upward inflation pressures with recession risks, leaning towards only one rate cut this year [3]

医药、贵金属板块涨幅居前，诺瓦瓦克斯医药涨超15%，联合健康涨超8%，Moderna涨超6%；美国黄 金公司涨超5%，埃氏金业、金田、吉利德科学、渤健公司涨超3%。 美股小幅收高 当地时间周一（5月19日），美股周一小幅收高，标普500指数连续第六个交易日上涨，道指涨0.32%， 纳指涨0.02%，标普500指数涨0.09%。 板块方面，标普500指数十一大板块七涨四跌。医疗板块和必需消费品板块分别以0.96%和0.42%涨幅领 涨，能源板块和非必需消费品板块分别以1.55%和0.27%跌幅领跌。 医药、贵金属板块涨幅居前，诺瓦瓦克斯医药涨超15%，联合健康涨超8%，Moderna涨超6%；美国黄 金公司涨超5%，埃氏金业、金田、吉利德科学、渤健公司涨超3%。 热门中概股涨跌不一。纳斯达克中国金龙指数（HXC）收跌0.17%。小牛电动跌超12%，哔哩哔哩跌近 5%，小鹏汽车跌超3%，理想汽车、蔚来跌超1%，金山云涨超2%，拼多多、京东涨幅不足1%。 美联储三大官员对降息持"观望"态度。 当地时间周一（5月19日），美股小幅收高，标普500指数连续第六个交易日上涨，道指涨0.32%，纳指 涨0.02%，标普50 ...

美联储三大官员对降息持"观望"态度。纽约联储主席威廉姆斯表示，在面对不确定的经济前景之际，货币政策决策者可能尚未准备好在9月份之前降低利率。 亚特兰大联储主席博斯蒂克 表示，在 当前美联储试图平衡通胀上行压力与经济衰退风险的背景下，他倾向于今年只降息一次。 美联储三大官员对降息持"观望"态度。 当地时间周一（5月19日），美股小幅收高，标普500指数连续第六个交易日上 涨，道指涨0.32%，纳指涨0.02%，标普500指数涨0.09%。市场基本消化了穆 迪下调美国信用评级的影响。 医药、贵金属板块涨幅居前，诺瓦瓦克斯医药涨超15%，联合健康涨超8%，Moderna涨超6%；美国黄金公司涨超5%，埃氏金业、金田、吉利德科学、渤健公 司涨超3%。 美股小幅收高 当地时间周一（5月19日），美股周一小幅收高，标普500指数连续第六个交易日上涨，道指涨0.32%，纳指涨0.02%，标普500指数涨0.09%。 板块方面，标普500指数十一大板块七涨四跌。医疗板块和必需消费品板块分别以0.96%和0.42%涨幅领涨，能源板块和非必需消费品板块分别以1.55%和 0.27%跌幅领跌。 医药、贵金属板块涨幅居前，诺瓦瓦克斯 ...

Group 1 - Novavax's COVID-19 vaccine, Nuvaxovid, received full approval from the FDA, leading to a nearly 26% surge in its stock price during pre-market trading [1] - The FDA approved Nuvaxovid for individuals aged 65 and above but restricted its use for those aged 12-64 with underlying health conditions [2] - The approval is based on data from a pivotal late-stage study demonstrating the vaccine's safety and effectiveness [3] Group 2 - Nuvaxovid is now the only non-mRNA-based COVID-19 vaccine available in the U.S., providing an alternative to mRNA vaccines from Moderna and Pfizer [6] - Sanofi acquired exclusive global marketing rights for Nuvaxovid, triggering a $175 million milestone payment upon full approval, along with ongoing tiered royalties on future sales [7] - Novavax faced delays in vaccine approval and launch, impacting its sales during the previous vaccination season, but aims to participate early in the upcoming season [9]

自中美经贸高层会谈达成重要共识后，美股市场接连反弹走高。 当地时间5月16日，美股三大股指全线收涨，道琼斯工业指数涨0.78%，标普500指数涨0.7%，纳斯达克指数涨0.52%。本周以来，道琼斯工 业指数涨3.41%，标普500指数涨5.27%，纳斯达克指数涨7.15%。 | 序号 | 代码 | 名称 | 现价 | 涨跌 | 涨跌幅 | 年初至今 | | --- | --- | --- | --- | --- | --- | --- | | 1 | DJI | 道琼斯工业指数 | 42654.74 | 331.99 | 0.78% | 0.26% | | 2 | IXIC | 纳斯达克指数 | 19211.10 | 98.78 | 0.52% | -0.52% | | 3 | SPX | 标普500 | 5958.38 | 41.45 | 0.70% | 1.30% | 欧洲股市方面，欧洲三大股指收盘全线上涨，德国DAX指数涨0.3%，法国CAC40指数涨0.42%，英国富时100指数涨0.59%。本周以来，德 国DAX指数涨1.14%，法国CAC40指数涨1.85%，英国富时100指数涨1.52%。 | ...

Market Performance - On May 16, US stock indices closed higher, with the Dow Jones Industrial Average rising by 0.78%, the S&P 500 increasing by 0.7%, and the Nasdaq up by 0.52% [1] - For the week, the Dow Jones increased by 3.41%, the S&P 500 by 5.27%, and the Nasdaq by 7.15% [1] European Market - European stock indices also saw gains, with the DAX up by 0.3%, CAC40 rising by 0.42%, and FTSE 100 increasing by 0.59% [2] - For the week, the DAX rose by 1.14%, CAC40 by 1.85%, and FTSE 100 by 1.52% [2] Major Tech Stocks - Most major US tech stocks saw increases, with Tesla up over 2%, Google rising over 1%, and Nvidia increasing by 0.35% [5] - However, Apple and Facebook experienced slight declines, with Apple down by 0.09% and Facebook down by 0.56% [5] Chip Sector - The semiconductor sector faced declines, with the Philadelphia Semiconductor Index down by 0.21% [6] - Notable declines included Applied Materials dropping over 5% and Micron Technology rising over 2% [6] Banking Sector - US bank stocks showed mixed performance, with Bank of America up by 0.7% and Wells Fargo by 0.83%, while Citigroup fell by 0.38% [7] COVID-19 Related Stocks - Stocks related to COVID-19 saw collective gains, with Novavax rising by 7% and Moderna increasing by over 5% [8] Airline Sector - Most US airline stocks rose, with Southwest Airlines up over 2% and American Airlines increasing by 0.85% [9] Economic Data - The University of Michigan's consumer confidence index for May dropped to 50.8, the second-lowest in history, with inflation expectations at 7.3%, the highest since 1981 [11] - April's import price index rose by 0.1% month-on-month, contrary to expectations of a decline [12] Federal Reserve Insights - Federal Reserve's Bostic indicated a potential rate cut this year due to economic uncertainties, projecting a growth rate of 1% or 0.5% [12] - Fed Chair Powell noted plans to reduce staff by 10% over the coming years [13] Chinese Stocks - Chinese stocks listed in the US mostly rose, with the Nasdaq Golden Dragon China Index up by 0.52% [15] - Notable gainers included Xiaopeng Motors rising nearly 14% and NIO increasing by about 12% [15] Oil Prices - International oil prices strengthened, with WTI crude oil rising by 1.28% to $61.93 per barrel [18] - Brent crude oil increased by 1.36% to $65.41 per barrel [18] Commodity Futures - Chicago Board of Trade agricultural futures saw declines across the board, with soybean futures down by 0.02% and corn futures down by 1.23% [18]

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in the context of investments and trading [1]. Group 1 - The website provides general news, publications, and personal analysis intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to consider their financial situation and needs before relying on the information provided [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to perform their own research and understand the risks involved before making investment decisions [1].

Group 1: Investment Opportunities - Equity markets present bargains with stocks that have underperformed but may rebound as conditions improve [1] - Moderna is highlighted as a beaten-down stock with promising prospects due to its advancements in mRNA technology and a strong pipeline of potential products [2][4] - Moderna's revenue guidance is projected at $2 billion, primarily from its COVID vaccine efforts, and the company plans to cut operating expenses by $1.4 billion to $1.7 billion by 2027 [8][9] Group 2: Company-Specific Analysis - Moderna - Moderna's mRNA-4157, a personalized cancer vaccine, has shown strong results in phase 2 studies and is currently in phase 3 trials [6] - The company is also developing a standalone influenza vaccine and a combined COVID/flu shot, both nearing approval [7] - Despite a decline in stock performance over the past three years, Moderna's potential for growth remains strong due to its innovative pipeline and cost-cutting measures [9] Group 3: Investment Risks - Teladoc Health, a telemedicine company, has seen a slowdown in revenue growth and remains unprofitable despite high gross margins [10] - In the first quarter, Teladoc's revenue decreased by 3% year over year to $629.4 million, with a net loss per share of $0.53 [11] - The company faces significant challenges, including a competitive landscape and declining membership in its therapy service, BetterHelp [13][14]